Phase II study of pyrotinib plus nanoparticle albumin-bound (nab)-paclitaxel as adjuvant therapy for lymph node-negative (N0) or micrometastatic (N1mi), HER2-positive early breast cancer (PHAEDRA)

Changjun Wang,Yidong Zhou,Yan Lin,Feng Mao,Jinghong Guan,Xiaohui Zhang,Songjie Shen,Xuejing Wang,Yanna Zhang,Bo Pan,Ying Zhong,Li Peng,Xi Cao,Ru Yao,Xingtong Zhou,Chi Xu,Ying Xu,Qiang Sun

CANCER RESEARCH（2022）

引用 0|浏览48

暂无评分

AI 理解论文

溯源树

样例

生成溯源树，研究论文发展脉络

Chat Paper

正在生成论文摘要